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Altered expression of rat renal cortical OAT1 and OAT3 in
response to bilateral ureteral obstruction.
Background. Bilateral ureteral obstruction (BUO) is char-
acterized by the development of hemodynamic and tubular le-
sions. However, little is known about the expression of organic
anion renal transporters. The objective of this work was to study
the renal excretion of p-aminohippurate (PAH) and the cortical
renal expression of the organic anion transporter 1 (OAT1) and
organic anion transporter 3 (OAT3) in BUO rats.
Methods. Male Wistar rats underwent bilateral obstruction of
the proximal ureters for 24 hours (BUO) or sham operation. Af-
ter 24 hours of ureteral releasing, the following studies were per-
formed: PAH renal excretion employing conventional clearance
techniques and OAT1 and OAT3 abundance (homogenates, in-
tracellular and basolateral plasma membrane fractions from
renal cortex) using immunoblotting and immunocytochemi-
cal techniques (light microscopic and confocal immunofluores-
cence microscopic analysis).
Results. BUO rats showed a lower renal excretion of PAH.
In obstructed kidneys, immunoblotting revealed a significant
decrease in the abundance of both OAT1 and OAT3 in ba-
solateral plasma membranes from renal cortex. An increase of
OAT1 expression was observed in homogenates and in intracel-
lular membrane fractions in kidneys from BUO rats compared
with sham-operated ones, indicating an internalization of this
carrier. Immunocytochemical techniques confirmed these re-
sults. On the contrary, OAT3 expression was reduced both in
homogenates and in intracellular membrane fractions in ob-
structed kidneys.
Conclusion. BUO was associated with down-regulation of
OAT1 and OAT3 in basolateral plasma membranes from prox-
imal tubule cells, thus these carriers may play important roles
in the impaired organic anion excretion displayed in the ob-
structed kidney.
Urinary tract obstruction is a serious and common clin-
ical condition, which is associated with increased intralu-
Key words: organic anions, ureteral obstruction, renal depuration,
OAT1, OAT3.
Received for publication March 14, 2005
and in revised form June 8, 2005
Accepted for publication July 14, 2005
C© 2005 by the International Society of Nephrology
minal pressure in the ureter and renal tubules that may
cause renal parenchymal damage through a series of di-
rect and indirect effects [1]. Obstruction of the urinary
tract has marked effects on renal blood flow, glomerular
filtration rate (GFR), tubular function, and parenchymal
structure [1, 2].
The renal tubular transport of organic anions plays an
essential role in the removal of xenobiotics, such as drugs,
numerous chemicals contained in our environment and
some metabolites out of the body. The secretory transport
process is performed effectively by two distinct classes of
transporters: one localized at the basolateral membranes
to mediate cellular uptake of substrates from blood and
the other at the brush-border membranes to mediate exit
of cellular substrates into the tubular lumen [3]. Organic
anion transporter 1 (OAT1, Slc22a6) and organic anion
transporter 3 (OAT3, Slc22a8) are involved in the organic
anion transport into the cell at the basolateral membrane
[4–6]. Immunocytochemical studies in rats showed that
OAT1 is detected exclusively in the proximal tubules
and OAT3 is localized in the proximal tubule, cortical
and medullary thick ascending limb of Henle’s loop, con-
necting tubules, and cortical and medullary collecting
ducts [7]. Both OAT1 and OAT3 support organic anion/a-
ketoglutarate exchange [8]. OAT1 has a high affinity for
p-aminohippurate (PAH) and does not support estrone
sulfate transport, whereas OAT3 has a high affinity for es-
trone sulfate and a weaker interaction with PAH [8]. Lit-
tle is known about the modulation of these transporters,
especially about the aspects of OAT1 and OAT3 regula-
tion concerning the body’s response to disease states. In
our laboratory we have demonstrated modifications in
the expression of OAT1 in kidneys from rats with differ-
ent pathologies such as arterial calcinosis [9], extrahepatic
cholestasis [10], and chronic renal failure [11].
We have recently demonstrated a diminished renal
elimination of organic anions clearance of PAH in
adult male Wistar rats with bilateral ureteral obstruction
(BUO) [12]. We have now studied the effects of ureteral
obstruction on the abundance of OAT1 and OAT3 in
homogenates and basolateral plasma membranes and
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intracellular membrane fractions from rat kidney cortex
using immunoblotting and immunocytochemical tech-
niques (light microscopic and confocal immunofluores-
cence microscopic analysis).
METHODS
Experimental animals
Male Wistar rats aged from 110 to 130 days old were
used throughout the study (380 to 410 g in body weight).
Animals were allowed free access to a standard labora-
tory chow and tap water, and were housed in an environ-
ment of constant temperature and humidity with regular
light cycles (12 hours) during the experiments. The an-
imals were cared for in accordance with the principles
and guidelines for the care and use of laboratory animals.
For surgical procedures the animals were anaesthetized
with sulfuric ether and ureters’ ligation and release were
performed as previously described [12]. The abdominal
cavity was opened, and 2-0 silk ligature was placed at
both proximal ureters. After closure of the abdomen, the
animals were kept for 24 hours while they were given
food and water ad libitum. The rats were considered to
have a successful ureteral obstruction when ureteral di-
ameter was > 2 mm and hydronephrosis was evident. The
ureteral obstruction was released after 24 hours and the
rats, referred as BUO rats, were kept alive for 24 hours
thereafter. After this time, the rats were anesthetized
with sodium thiopental (70 mg/kg body weight, intraperi-
toneally) and all the measurements were recorded. Cor-
responding control groups, referred as sham-operated
group, were treated the same, except that no ureteral ob-
struction was performed. A total of 40 rats were used
in this study. Twenty rats underwent ureteral obstruc-
tion and 20 rats underwent sham operation. The day of
the experiments blood samples were withdrawn from the
tail artery in order to measure urea plasma levels. Urea
analyses were performed with optimized spectrophoto-
metric technique, employing a commercial kit (Wiener
Laboratory, Rosario, Argentina).
Renal PAH excretion studies
These studies were performed as previously described
[12–15]. A group of BUO (N = 4) and sham (N = 4)
animals were anesthetized as described. Femoral vein
and artery were cannulated (PE50) (Intramedic, Franklin
Lakes, NJ, USA) and a bladder catheter (3 mm inner
diameter) was inserted through a suprapubic incision.
Animals were maintained in restraining cages through-
out the experiment to facilitate the collection of urine.
A priming dose of inulin (0.6 mg/kg body weight) and
PAH (30 mg/kg body weight) in 1 mL of saline solu-
tion was administered through the venous catheter. Then,
a solution containing inulin (18 g/L), PAH (6 g/L) and
saline solution (9 g/L) was infused through the venous
catheter employing a constant infusion pump (Pump 22;
Harvard Apparatus, Cambridge, MA, USA) at a rate
of 1 mL/hour/100 g body weight. After equilibrating for
45 minutes, urine was collected during two 20-minute pe-
riods. Blood from the femoral artery was obtained at the
midpoint of each clearance period. Arterial blood pres-
sure was estimated throughout the experiments with a
manometer inserted in the femoral artery. The GFR was
calculated from the clearance of inulin. Fractional excre-
tion of PAH was also calculated by conventional formulas
for each animal. PAH concentrations in plasma and urine
were determined by the method of Waugh and Beall [16]
and inulin concentrations were determined by the proce-
dure of Roe [17]. Sodium and potassium clearance were
calculated after the assay of sodium and potassium con-
centrations in plasma and urine by flame photometry. The
volume of urine was measured by gravimetry.
Preparation of membrane fractions
BUO and sham-operated rats were anesthetized as pre-
viously described and kidneys were rapidly removed. The
renal tissue was cleaned, dried, weighed, and placed in
saline.
Intracellular membrane fractions preparations. Intra-
cellular membrane fractions were obtained as described
by Marples et al [18] with some modifications, from BUO
(N = 4) and sham-operated (N = 4) rats. This technique
is based in a standard preparatory method for membrane
fractions described for kidneys and other tissues [19–21].
The renal cortex was homogenized in ice-cold isolation
solution containing 250 mmol/L sucrose, 10 mmol/L tri-
ethanolamine, and 0.1 mg/mL phenylmethylsulfonyl flu-
oride (PMSF). The homogenates were centrifuged at
1000 × g for 10 minutes to remove nuclei and incom-
pletely homogenized membrane fragments. To increase
yield, this pellet was rehomogenized as described above
and was spun again at 1000 × g for 10 minutes. The su-
pernatants from the two 1000 × g centrifugations were
pooled. The supernatant was subjected to two subsequent
centrifugations. The pooled supernatant was centrifuged
at 17,000 × g for 20 minutes. Then, the supernatant from
17,000 × g centrifugation was spun at 200,000 × g for
60 minutes to obtain a low-density fraction enriched in in-
tracellular membrane fractions. The resulting pellet was
resuspended in isolation solution, and total protein con-
centration in these membrane fractions were measured
using the method of Sedmak and Grossberg [22].
Basolateral membrane preparations. The preparations
of basolateral membranes from sham-operated (N = 8)
and BUO (N = 8) rats were done by a modification of
the method described by Jensen and Berndt [23] as pre-
viously reported by us [9, 11, 24]. Approximately 4 g of
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kidney cortex were placed in a Dounce homogenizer con-
taining 50 mL of 250 mmol/L sucrose, 5 mmol/L Tris-
Hepes, pH 7.40, and 0.1 mg/mL PMSF. After four gentle
strokes with the loose fitting pestle, the suspension was
homogenized further with a motor-driven Teflon pestle
(600 rpm/5 strokes) and spun down for 15 minutes at
1200 × g. The supernatant was aspirated and spun for
15 minutes at 22,000 × g. The fluffy beige upper layer of
the resulting pellet (crude plasma membranes) was resus-
pended in about 1 mL of supernatant and added to 19 mL
of buffered sucrose. The membrane suspension was ho-
mogenized gently through a 16-gauge gavage needle fol-
lowed by the addition of 3.7 mL of 100% Percoll. The
Percoll membranes mixture was spun for 30 minutes at
39,250 × g. The top clear layer was discarded and the top-
most dark band was removed. This layer was composed
primarily of basolateral membranes as established by
marker enzymes analysis. Basolateral membranes were
brought up in KCl buffer (85 mmol/L KCl, 83 mmol/L
sucrose, and 2 mmol/L Hepes-Tris, pH 7.40) at a ratio
of 8 mL/g original cortex wet weight. Then, basolateral
membranes were pelleted at 30,000×g for 30 minutes and
washed three times with the KCl buffer indicated. Finally,
basolateral membranes were resuspended in 300 uL of
250 mmol/L mannitol, 10 mmol/L Hepes-Tris, pH 7.40,
and 0.1 mg/mL PMSF. Protein quantification of sam-
ples was performed using the method of Sedmak and
Grossberg [22].
Purification of isolated membrane fractions
The purity of isolated membrane fractions was
ascertained through analyses of marker enzymes,
Na,K-ATPase for basolateral membranes and glucose
6-phosphatase for intracellular membrane fractions. Glu-
cose 6-phosphatase is an endoplasmic reticulum marker.
Endoplasmic reticulum accounts for more than 60% of
intracellular membranes [25].
Na,K-ATPase activity was estimated as the difference
between the amounts of inorganic phosphate liberated in
the absence (total ATPase) and in the presence (Mg+2-
ATPase) of ouabain [26]. The release of inorganic phos-
phate was measured according to Widnell et al [27].
Glucose 6-phosphatase was assayed by the method de-
scribed by Aronson and Touster [28].
The activity of Na,K-ATPase was enriched in baso-
lateral membrane tenfold over that in a crude cortical
homogenate. The enrichment of glucose 6-phosphatase
was 0.95-fold in basolateral membrane showing a small
contamination with intracellular membrane fractions. On
the contrary, glucose 6-phosphatase was enriched 3.10-
fold over crude homogenate in the intracellular mem-
brane fractions. Na,K-ATPase was enriched 0.90-fold
in intracellular membrane fractions, which shows low
contamination of intracellular membrane fractions with
basolateral membranes. Enrichment and purity of mem-
branes were comparable to those reported previously
[13, 29–31] and similar between sham-operated and BUO
groups.
Electrophoresis and immunoblotting
Homogenates, intracellular membrane fractions, and
basolateral membrane fractions were boiled for 3 minutes
in the presence of 1% 2-mercaptoethanol/2% sodium do-
decyl sulfate (SDS). Samples were applied to an 8.5%
polyacrylamide gel, separated by SDS-polyacrylamide
gel electrophoresis (PAGE), and then electroblotted
to nitrocellulose membranes. For comparison between
groups of animals, staining with ponceau red revealed
that equal quantities of proteins were deposited [10,
11, 24, 32]. The nitrocellulose membranes were incu-
bated overnight with 5% nonfat dry milk in phosphate-
buffered saline (PBS) containing 0.1% Tween 20 (PBST).
After being rinsed with PBST, the membranes were
then incubated with a commercial rabbit polyclonal an-
tibody against rat OAT1 (1.25 lg/mL) for 2 hours at
room temperature or with noncommercial rabbit poly-
clonal antibody against rat OAT3 (at a dilution if 1:1000)
overnight at 4◦C. The specificity of the anti-OAT3 an-
tibody was described elsewhere [7]. Membranes were
incubated for 1 hour with a peroxidase-coupled goat
antirabbit IgG (Bio-Rad, Hercules, CA, USA). After fur-
ther washing with PBST, blots were processed for de-
tection using a commercial kit (Opti-4CN) (Bio-Rad)
for OAT1 and enhanced chemiluminescence (ECL) sys-
tem (Amersham, Piscataway, NJ, USA) for OAT3. To
investigate the specificity of the bands, an absorption
test was performed. The OAT1 peptide (1.25 ug/mL) or
OAT3 peptide (0.50 mg/mL) were added to the OAT1
antibody-specific solution or OAT3 antibody-specific so-
lution, respectively, and incubated for 2 hours. Using
these preabsorbed antibodies, Western blot analysis were
performed as described above. A densitometric quantifi-
cation of Western blot signal intensity of membranes was
performed.
Immunocytochemistry microscopy
Kidneys from sham-operated (N = 4) and BUO (N =
4) were briefly perfused with saline, followed by per-
fusion with periodate-lysine-paraformaldehyde solution
(0.01 mol/L NaIO4, 0.075 mol/L lysine, and 0.0375 mol/L
phosphate buffer, with 2% paraformaldehyde, pH 6.20),
through an abdominal cannula. Kidneys slices were im-
mersed in periodate-lysine-paraformaldehyde solution
at 4◦C overnight. The tissue was embedded in para-
ffin. Paraffin sections were cut. After deparaffining, the
sections were incubated with 3% H2O2 for 15 minutes
(to eliminate endogenous peroxidase activity) and then
with blocking serum for 30 minutes. The sections were
then incubated with noncommercial polyclonal antibod-
ies against OAT1 (diluted 1:1000) or OAT3 (diluted
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1:1000) overnight at 4◦C. The specificity of the both anti-
bodies was described elsewhere [7, 33]. The sections were
rinsed with PBST.
Light microscopic analyses. The sections were incu-
bated with biotinylated secondary antibody against rabbit
immunoglobulin for 1 hour (biotinylated Ig) (Multi-Link
Biogenex, San Ramon, CA, USA). After being rinsed
with PBST, the sections were incubated for 30 minutes
with horseradish peroxidase–conjugated streptavidin so-
lution (Streptavidin/horseradish peroxidase complex)
(Multi-Link Biogenex). In order to detect horseradish
peroxidase labeling, a peroxidase substrate solution with
diaminobenzidine (DAB) (0.05% DAB in PBST with
0.05% H2O2) was used. The sections were counterstained
with hematoxylin before being examined under a light
microscope.
Confocal immunofluorescence microscopic analyses.
The sections were incubated with Alexa 488 fluoro-
chrome–conjugated goat antirabbit IgG (1:1000) (Molec-
ular Probes, Eugene, OR, USA) overnight at 4◦C.
Sections were washed with PBST and then mounted. Sec-
tions were viewed on a Zeiss Axiophot microscope (Carl
Zeiss, Inc., Thornwood, NY, USA) equipped with an epi-
fluorescence detector and a Bio-Rad MRC 1260 confocal
imaging system.
Controls using preimmune serum, antiserum absorbed
with excess synthetic peptide (as described above), or
omission of primary or secondary antibody revealed no
labeling.
Materials
Chemicals were purchased from Sigma Chemical Co.
(St. Louis, MO, USA) and were analytical grade pure.
Polyclonal antibody against OAT1 and the OAT1 peptide
for Western blot were purchased from Alpha Diagnostic
International (San Antonio, TX, USA). The polyclonal
antibody against OAT1 for immunocytochemical stud-
ies and polyclonal antibody against OAT3 and the OAT3
peptide for both Western and immunocytochemical stud-
ies were noncommercial [7, 33].
Statistical analysis
Statistical analyses were performed using an unpaired
t test. When variances were not homogeneous, a Welch
correction was employed. P values less to 0.05 was con-
sidered significant. Values are expressed as mean ± SEM.
For these analyses GraphPad software was used. For
densitometry of immunoblots, samples from obstructed
kidneys were run on each gel with corresponding sham
kidneys. Abundance of OAT1 and OAT3 in the samples
from the experimental animals was calculated as percent-
age of the mean sham control value for that gel.
Table 1. Body weight, mean arterial blood pressure, glomerular
filtration rate, sodium and potassium plasma levels ([Na]p, [K]p),
sodium and potassium clearance (ClNa and ClK) in sham-operated
and bilateral ureteral obstruction (BUO) rats
Sham (N = 4) BUO (N = 4)
Body weight g 330 ± 10 328 ± 8
Mean arterial pressure mm Hg 116 ± 3 129 ± 7
Glomerular filtration rate 0.60 ± 0.05 0.13 ± 0.02a
mL/min/100 g body weight
[Na]p mEq/L 140 ± 5 139 ± 4
[K]p mEq/L 3.37 ± 0.13 3.52 ± 0.25
ClNa lL/min/100 g body weight 7.21 ± 1.10 7.13 ± 0.81
ClK lL/min/100 g body weight 0.181 ± 0.031 0.108 ± 0.013
Results are expressed as mean values ± SEM.
aP < 0.05.
RESULTS
Body weight, mean arterial blood pressure, GFR,
sodium and potassium plasma levels ([Na]p, [K]p),
sodium and potassium clearance (ClNa and ClK) in sham-
operated and BUO rats are displayed in Table 1. GFR
was significantly diminished in BUO rats as previously
observed in our laboratory [12].
As demonstrated in Figure 1, BUO rats showed an
increase in urea plasma levels (Fig. 1A) as previously
described by Villar et al [12]. Thus, as expected, the exper-
imental rats developed a significant increase in nitroge-
nous waste products such as urea. A diminution in PAH
fractional excretion (Fig. 1B), was observed in BUO rats
as compared with sham-operated rats, corroborating the
altered renal elimination of organic anions previously de-
scribed [12].
Kidney cortex homogenates, basolateral membrane
and intracellular membrane fractions from sham-
operated and BUO animals were subjected to im-
munoblot analysis for OAT1 protein. Figure 2 shows an
increase of approximately 55% in the expression of OAT1
both in homogenates (Fig. 2A) and intracellular mem-
brane fractions (Fig. 2B) from kidneys of BUO rats. On
the contrary, a marked decrease was observed in basolat-
eral membranes (Fig. 2C) from treated rats. The OAT1
protein disappeared when the antibody was preabsorbed
to the synthetic antigen peptide (data not shown).
Immunocytochemistry using horseradish peroxidase–
conjugated secondary antibody for light microscopy con-
firmed the reduced OAT1 expression in basolateral
plasma membranes from BUO rats (Fig. 3B). Sham-
operated rats showed abundant OAT1 labeling in ba-
solateral domains (Fig. 3A). To further characterize the
distribution of OAT1 labeling in proximal tubule cells,
immunofluorescence was used (Fig. 4). Confocal im-
munofluorescence studies also revealed a decrease OAT1
labeling in basolateral plasma membranes and a punctate
labeling for OAT1 was distributed widely throughout the
cytoplasm in kidneys from BUO rats (Fig. 4B) consistent
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Fig. 1. Urea plasma levels (A) and fractional excretion (EF) of p-
aminohippurate (PAH) (B) in sham-operated (N = 4) and bilateral
ureteral obstruction (BUO) (N = 4) rats. Results are expressed as
means ± SEM. #P < 0.05.
with its occurrence primarily in intracellular membrane
fractions. Thus the pattern observed closely parallels the
results for immunoblotting.
Western blots of kidney cortex homogenates, basolat-
eral membranes, and intracellular membrane fractions
from sham-operated and BUO rats showed signals for
OAT3. In Figure 5 it is possible to observe that OAT3
abundance was significantly decreased in kidney cortex
homogenates (Fig. 5A), intracellular membrane fractions
(Fig. 5B), and basolateral membranes (Fig. 5C) from
BUO rats as compared with sham-operated rats. These
signals were not observed when the antibody was preab-
sorbed with the OAT3 peptide (data not shown).
Immunocytochemistry studies using horseradish
peroxidase–conjugated secondary antibody for light
microscopy showed staining for OAT3 in many parts of
the nephron such as the proximal tubule (S1, S2, and S3),
the distal and the collecting duct as previously described
[7]. Sham-operated rats showed OAT3 labeling in
basolateral membrane domain of renal tubular cells and
inside the cytoplasm (Fig. 6A). Reduced labeling was
seen in basolateral membranes and inside the cytoplasm
of proximal tubules from obstructed kidneys (Fig. 6B).
Confocal immunofluorescence microscopy showed
the basolateral membrane localization of OAT3 and
the mostly OAT3 intracellular localization was better
appreciated (Fig. 7A). An important decrease of OAT3
both in basolateral membranes and inside the cytoplasm
was observed in the proximal tubules from kidneys of
BUO rats (Fig. 7B). This pattern parallels the data from
immunoblotting study.
A slightly lower staining intensity for OAT3 was also
observed in collecting tubules from BUO rats with both
immucytochemistry techniques.
DISCUSSION
Bilateral ureteral obstruction is an important cause of
acute renal failure. After 24 hours of ureteral release, we
have observed a marked increase in urea plasma levels,
which corroborates the presence of acute renal failure in
this experimental model. The pathophysiologic mecha-
nisms accompanying ureteral obstruction have not been
completely elucidated.
The kidneys play a crucial role in the elimination of or-
ganic anions [3, 8]. The major contribution to elimination
comes from proximal tubular secretion, which is medi-
ated by specific transporters located in basolateral and
apical membranes of the epithelial cells. Previous studies
of probenecid-sensitive PAH secretion have indicated a
multispecific transport system, represented by a tertiary
active PAH/a-ketoglutarate exchange localized in the
proximal tubule cell, as the pivotal mechanism for organic
anion secretion in the nephron. This transport is indirectly
coupled to the sodium gradient, which is generated by the
Na,K-ATPase pump. From mammalian kidney, two mul-
tispecific organic anion transporters, OAT1 and OAT3,
have been cloned, immunocytochemically and function-
ally characterized, and found to transport PAH in addi-
tion to a variety of other substrates [8, 34].
In the present study, we have used differential centrifu-
gation, semiquantitative immunoblotting, and immuno-
cytochemistry to investigate the possibility that BUO is
associated with an altered abundance of OAT1 and OAT3
proteins.
The main finding of the present study is that BUO re-
sults in a decreased expression of OAT1 and OAT3 in
basolateral membranes of renal tubular cells. In parallel
the excretion of PAH is impaired in BUO rats. Addi-
tionally, to the lower number of OAT1 and OAT3 trans-
porters units in basolateral membrane is important to
consider that the activity of the Na,K-ATPase is reduced
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Fig. 2. Right, renal cortex homogenates (50 lg proteins) (A), intracellular membrane fractions (60 lg proteins) (B), and basolateral membranes
(50 lg proteins) (C) from kidneys of sham-operated and bilateral ureteral obstruction (BUO) rats were separated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) (8.5%) and blotted onto nitrocellulose membranes. Organic anion transporter 1 (OAT1) was
identified using commercial polyclonal antibodies as described in the Methods section. Left, densitometric quantification of OAT1. Sham levels
were set at 100%. Each column represents mean ± SEM from experiments carried out in triplicate on four different cortex homogenate, basolateral
membranes, and intracellular membrane fractions preparations for each experimental group. #P < 0.05.
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Sham BUO
Fig. 3. Immunoperoxidase immunocyto-
chemistry for organic anion transporter 1
(OAT1) in the renal cortex of sham-operated
(A) and BUO rats (B). Serial sections
from each rat kidney were stained using
a noncommercial antirat OAT1 antibody
(crude immune serum). OAT1 labeling
was seen at the basolateral domains of
proximal tubule cells. In BUO rats, it can
be seen a great reduction in basolateral
membrane labeling for OAT1. These figures
are representatives of typical samples from
four rats (magnification ×400).
Sham BUO
BA
Fig. 4. Immunofluorescence localization of
organic anion transporter 1 (OAT1) in the re-
nal cortex of sham-operated (A) and BUO
rats (B). Serial sections from each rat kid-
ney were stained using a noncommercial anti-
rat OAT1 antibody (crude immune serum).
In BUO rats, it can be seen OAT1 label-
ing throughout the cytoplasm in the proximal
tubules, whereas labeling basolateral mem-
branes are greatly reduced. These figures are
representatives of typical samples from four
rats (magnification ×400).
in this experimental model [12]. The reduction of its activ-
ity might condition the functionality of the organic anion
transporters remaining in the membrane.
The intracellular signals responsible for OAT1 and
OAT3 down-regulation in renal cortex basolateral mem-
branes from BUO rats remain unclear. In a number of
nonmammalian and mammalian renal proximal tubule
model systems, peritubular uptake and/or transepithe-
lial secretion of prototypical organic anions have been
demonstrated to be inhibited by agents that stimulate
protein kinase C [35–37]. It has been also demonstrated
that OAT1 and OAT3, when heterologously expressed
in oocytes or mammalian cells, are inhibited by more
or less selective protein kinase C activators [38–40]. In
this connection, Wolff et al [41] have recently demon-
strated by that protein kinase C induces human OAT1
down-regulation through carrier retrieval from the cell
membrane and does not involve phosphorylation. The
mechanisms by which protein kinase C produces OAT3
down-regulation have not yet been described. It is well
known that angiotensin II [42] modulates renal proxi-
mal tubule function via activation of protein kinase C. In
this regard, it has been demonstrated that angiotensin II
has an increased expression in the presence of ureteral
obstruction [1, 43, 44]. Moreover, it has been recently
described that the epidermal growth factor (EGF) up-
regulates OAT1 and OAT3 [45, 46]. Interestingly, EGF
expression is decreased in obstructive nephropathy [44].
In the present study, the decreased expression of OAT1
in basolateral membranes and its increase in intracellu-
lar membranes fractions might suggest an internalization
of membrane transporters or an inhibition of the recruit-
ment of preformed transporters into the membranes. Our
study describes for the first time “in vivo,” the expres-
sion of OAT1 in intracellular membranes. Probably, this
OAT1 pool is only microscopically put in evidence in the
presence of pathologic states. The increase of OAT1 ex-
pression in kidney homogenates from BUO rats, which
we have demonstrated previously [12], suggests an in-
creased synthesis or decreased degradation of the trans-
porter, in addition to the internalization demonstrated in
the present work.
On the contrary, OAT3 down-regulation in basolateral
membranes from kidneys of rats with BUO was accom-
panied by a decreased abundance both in intracellular
membranes and in homogenates indicating a decrease in
its synthesis or an increase in its degradation. The in-
tracellular granular staining observed for OAT3 both in
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Fig. 5. Right, renal cortex homogenates (50 lg proteins) (A), intracellular membrane fractions (40 lg proteins) (B), and basolateral membranes
(40 lg proteins) (C) from kidneys of sham-operated and bilateral ureteral obstruction (BUO) rats were separated by sodium docecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) (8.5%) and blotted onto nitrocellulose membranes. Organic anion transporter 3 (OAT3) was
identified using noncommercial polyclonal antibodies as described in the Methods section. Left, densitometric quantification of OAT3. Sham levels
were set at 100%. Each column represents mean ± SEM from experiments carried out in triplicate on four different cortex homogenate, basolateral
membranes, and intracellular membrane fractions preparations for each experimental group. #P < 0.05.
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Sham BUO
Fig. 6. Immunoperoxidase immunocyto-
chemistry for organic anion transporter3
(OAT3) in the renal cortex of sham-operated
(A) and BUO rats (B). Serial sections
from each rat kidney were stained using
a noncommercial antirat OAT3 antibody.
OAT3 labeling was seen at the basolateral
domains and inside the cytoplasm of prox-
imal tubule cells. In BUO rats, it can be
seen a reduced OAT3 labeling in both and
cytoplasm of proximal tubules. These figures
are representatives of typical samples from
four rats (magnification ×400).
Sham BUO
A B
Fig. 7. Immunofluorescence localization of
organic anion transporter 3 (OAT3) in the re-
nal cortex of sham-operated (A) and BUO
rats (B). Serial sections from each rat kidney
were stained using a noncommercial antirat
OAT3 antibody. OAT3 labeling was seen at
the basolateral domains of proximal tubule
cells and inside the cells. In BUO rats, it can
be seen a reduced OAT3 labeling throughout
the cytoplasm and in basolateral membrane
in the proximal tubules. These figures are rep-
resentatives of typical samples from four rats
(magnification ×400).
sham-operated and BUO rats (physiologic and patho-
logic conditions) indicates the localization of the pro-
tein in a vesicle population that may be involved in the
recycling of this transporter by means of endocytosis
and exocytosis. A similar finding was also described by
Ljubojevich et al [47].
Further research should also be directed toward delin-
eation of the molecular basis for transcriptional, trans-
lational and postranslational regulation of OAT1 and
OAT3 both in physiologic and pathologic conditions, be-
cause of their impact on the efficiency of the kidneys in ex-
creting endogenous and exogenous anionic compounds.
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